TETERBORO, N.J., July 17 /PRNewswire/ -- JELD-WEN, one of the world's
largest manufacturers of doors, windows, millwork and specialty wood products,
is offering employees and their spouses a chance to improve their health and
reduce their health care costs by participating in Blueprint for Wellness, a
comprehensive lifestyle and health assessment offered by Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services.
Under an agreement between JELD-WEN and Quest Diagnostics' Corporate
Health and Wellness business unit, approximately 20,000 JELD-WEN employees and
their spouses in the U.S. are eligible to participate in Blueprint for
Wellness at health fairs that began in June and will continue through August
at JELD-WEN facilities. The Blueprint for Wellness program provides
confidential health improvement recommendations to participants based on a
combination of lab results and self-reported data. Individuals who participate
receive an individualized health risk assessment report sent directly to their
homes.
"We strongly believe that employees who actively manage their own health
are healthier, happier and more productive," said Jennifer Johns, Wellness
Manager for JELD-WEN, whose North American headquarters are in Klamath Falls,
Oregon. "Our facilities are spread out across the country. Quest Diagnostics'
Blueprint for Wellness program provides the opportunity to reach everyone,
even in remote locations, with quality health information."
Quest Diagnostics is the nation's leading provider of diagnostic testing,
information and services with annual revenues of $3.4 billion in 2000. The
company's diagnostic testing yields information that enables health care
professionals and consumers to make better decisions to improve health. Quest
Diagnostics offers patients and physicians the broadest access to diagnostic
testing services through its national network of approximately 30 full-service
laboratories, 150 rapid response laboratories and more than 1,300 patient
service centers, where specimens are collected. Quest Diagnostics is the
leading provider of esoteric testing, and is the leader in routine medical
testing, drugs of abuse testing, and anatomic pathology testing. Through
partnerships with pharmaceutical, biotechnology and information technology
companies, Quest Diagnostics provides support to help speed the development of
health care insights and new therapeutics. Additional information can be
found on the Internet at: http://www.questdiagnostics.com.
SOURCE Quest Diagnostics Incorporated
CONTACT: Media - Gary Samuels, +1-201-393-5700, or Investors - Cathy
Doherty, +1-201-393-5030, both for Quest Diagnostics Incorporated/